IMVT: Immunovant Inc Kompaniya qiymatining sof foydaga nisbati
Immunovant, Inc. (IMVT) kompaniyasining median P/E dinamikasi yangi antitelolarning samaradorligi va patent huquqlariga oid kutishlar bilan bog'liq. Biomateriallar tahlilining robotlashtirilishi tadqiqotlarni tezlashtirmoqda, biroq daromadning yo'qligi va rezervlarning kamayishi moliyaviy bosimni keltirib chiqarmoqda. -14.20 ning joriy qiymati ko'rsatkichning haqiqiy miqdorini ko'rsatadi, bu esa naqd pul tanqisligi yuzaga kelishidan oldin aktivlar likvidligi muammolarini aniqlashga yordam beradi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_IMVT_-_Immunovant-Inc._-_PE-Multiple "IMVT: Immunovant, Inc. Biznesning o‘zini qoplash muddati 04.07.2022 - 13.11.2026 | 👁️GURU.Markets👁️")
Immunovant Corp (IMVT) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Immunovant, Inc.|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Immunovant Therapeutics|IMVT - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Immunovant, Inc.|IMVT - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Immunovant|Oraliq qoplama koeffitsiyenti immunovant.com
- foyda va bozor multiplikatorlari tafsilotlari:
IMVT - Kompaniyaning sof foydasi|Kelajakdagi foyda Immunovant, Inc.|IMVT - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Immunovant Inc|IMVT - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Immunovant, Inc.|IMVT - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun foyda Immunovant|IMVT - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi immunovant.com|IMVT - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Immunovant, Inc.
Kompaniyaning har tomonlama tahlili:immunovant.com IMVT
Xavflari yagona texnologik platformada jamlangan Immunovant, Inc. uchun taxminiy P/E -14.20 ko'rsatkichi uning antitelalari kengaytirilishiga oid bozor kutuvlarining o'lchovi bo'lib xizmat qiladi. Ushbu koeffitsient sof foyda orqali kapitalizatsiyaning qoplash muddatini belgilab, joriy qiymat va haqiqiy daromadlar o'rtasidagi muvozanatni aks ettiradi. Kompaniyaning P/E koeffitsiyenti o'zgarishlarini tahlil qilish orqali investor avtoimmun kasalliklarni davolash istiqbollariga nisbatan aktivning qanchalik past baholanganlik darajasini baholashi mumkin.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|KNSA - Narxning foydaga nisbati|grifols.com (GRFS) - Narx-foyda koeffitsiyenti|Adaptive Biotechnologies Corporation (ADPT) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Celldex Therapeutics Inc|Narx-foyda koeffitsiyenti AUPH|P/E multiplikatori BioCryst Corp|Narxning foydaga nisbati Vera Therapeutics, Inc. (VERA)|dianthustx.com - Narx-foyda multiplikatori|P/E multiplikatori PHVS (Pharvaris)|AbCellera Corp (ABCL) - Kapitalizatsiyaning foydaga nisbati|Tourmaline Corp - P/E multiplikatori|Biznesning o‘zini qoplash muddati Precigen Corp PGEN|Pharming Group N.V. (PHAR) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti nektar.com|Narxning foydaga nisbati Upstream Bio|Narx-foyda koeffitsiyenti Zenas Bio (ZBIO)|Narx-foyda koeffitsiyenti IMNM (Immunome Corp)|P/E multiplikatori Gossamer Bio Corp. (GOSS)|Narxning foydaga nisbati KalVista Pharmaceuticals KALV|SEPN: Narx-foyda multiplikatori|PVLA - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Savara Inc|RIGL (Rigel Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|ANAB (AnaptysBio Inc.) - Narxning foydaga nisbati|ATXS (Astria Therapeutics) - P/E multiplikatori|P/E multiplikatori engene.com|Narxning foydaga nisbati RAPT Therapeutics (RAPT)|aerovatetx.com - Narx-foyda multiplikatori|Aclaris - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati KYTX (Kyverna Therapeutics, Inc)|TLSA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CABA (cabalettabio.com)|VTYX: P/E multiplikatori|THTX - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Avalo Therapeutics Inc.|Narx-foyda multiplikatori ELDN (Eledon Pharmaceuticals, Inc)|P/E multiplikatori AGEN|Narx-foyda koeffitsiyenti climbbio.com CLYM|Zura Bio - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati aTyr Pharma Inc (ATYR)|Adagene Corp - P/E multiplikatori|Biznesning o‘zini qoplash muddati ImageneBio Inc IMA|shattucklabs.com (STTK) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Equillium|Narx-foyda koeffitsiyenti CNTB|Narxning foydaga nisbati IMUX|Narx-foyda koeffitsiyenti ATRA (Atara Biotherapeutics)|Bozor narxining sof foydaga nisbati IFRX|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|ACET (Adicet Bio Inc.) - Kapitalizatsiyaning sof foydaga nisbati|Celularity Corp - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Inc)|BRNS: P/E multiplikatori|Kezar Life Sciences Inc (KZR) - P/E multiplikatori|Narxning foydaga nisbati SAB Biotherapeutics|AKTX: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|Narx-foyda koeffitsiyenti q32bio.com QTTB|P/E multiplikatori GOVX (GeoVax Labs Inc)|P/E multiplikatori Edesa Biotech Corp EDSA|IBIO: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CARM (Carisma Therapeutics)|XTLB: P/E multiplikatori|BOLT - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati HCW Biologics, Inc.|Narx-foyda koeffitsiyenti Aptevo (APVO)|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|Narx-foyda koeffitsiyenti aditxt.com ADTX|GRI Bio - Narx-foyda koeffitsiyenti|P/E multiplikatori XORTX Therapeutics Inc XRTX|HIND - Narxning foydaga nisbati|REVB (Revelation Biosciences Corp) - Narx-foyda multiplikatori|INDP: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati scinai.com (SCNI)|CALI (CalciMedica Inc) - P/E multiplikatori|Affimed Therapeutics (AFMD) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Allakos Inc. (ALLK)|Narx-foyda koeffitsiyenti hookipapharma.com HOOK|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS - Narx-foyda koeffitsiyenti|OCEA: Narx-foyda koeffitsiyenti|TCBP - P/E multiplikatori|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
